Analysts Set Esperion Therapeutics, Inc. (NASDAQ:ESPR) PT at $6.42
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating […]
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating […]
